Surrey researchers Sign in
Pretreatment frequency of circulating IL-17(+)CD4(+) T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients
Journal article

Pretreatment frequency of circulating IL-17(+)CD4(+) T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

E Derhovanessian, V Adams, K Haehnel, A Groeger, H Pandha, S Ward and G Pawelec
INTERNATIONAL JOURNAL OF CANCER, Vol.125(6), pp.1372-1379
15/09/2009

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY IL-17(+) T-cells Tregs prostate cancer immunotherapy prognosis CHEMOKINE RECEPTOR CCR6 METASTATIC MELANOMA PERIPHERAL-BLOOD TGF-BETA IN-VIVO ANTITUMOR IMMUNITY TUMOR-REGRESSION CUTTING EDGE T(H)17 CELLS TH17 CELLS
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269392700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

53 readers on Mendeley
1 readers on CiteULike

Details

Usage Policy